# FDA 483 - Exel Inc. d/b/a DHL Supply Chain - March 13, 2020

Source: https://www.globalkeysolutions.net/records/483/exel-inc-dba-dhl-supply-chain/6d4687c7-89f5-4e32-850a-f837f18832d4

> FDA 483 for Exel Inc. d/b/a DHL Supply Chain on March 13, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Exel Inc. d/b/a DHL Supply Chain
- Inspection Date: 2020-03-13
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: Exel Inc. d/b/a DHL Supply Chain in Manchester, PA, a drug repacker/relabeler, received a Form 483 with two observations. The inspection revealed that the firm failed to thoroughly investigate unexplained discrepancies related to incorrect drug quantities in distributed products. Additionally, the firm did not conduct GMP training with sufficient frequency for employees involved in repacking and relabeling operations.

## Related Officers

- [Pharmacy Intern/Certified Pharmacy Technician](https://www.globalkeysolutions.net/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)

Company: https://www.globalkeysolutions.net/companies/exel-inc-dba-dhl-supply-chain/22cbe968-37d7-4641-9bb8-c887004cb0fd

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8